A Year at the Heart of Regulatory Decision Making

by ANCEL.LA SANTOS, Senior Policy Advisor – Europe

It’s that time of year when we reflect on our activities and achievements of the last 12 months. It’s been a busy year across the organisation, and our European Projects have been no exception! Our Senior Policy Advisor, Ancel.la Santos, looks back at a year of hard work at the heart of regulatory decision making in the European Union (EU),

Can the WHO Set the Right Course for Antibiotics?

by MATTHEW ENEVOLDSON, Communications Intern

As a typically awkward teenager, I was, as many are, occasionally afflicted by an outbreak of spots. Whilst these were embarrassing, they were by no means terrible. Even at their worst, they were nothing but a shadow of those of the kid, resident in every school, who is plagued by acne.

The EU-US Trade Deal Could Leave Europeans Sick

by TESSEL MELLEMA and ALIÉNOR DEVALIÈRE
 
Some help us for a while. Some cure us entirely. No doubt, medicines—when they’re available and affordable—play a crucial role in helping us live better quality and longer lives than ever before. So, why, then, would the European Commission do anything that would risk citizens’ ability to access the medicines we need?

Tamiflu review shows desperate need for full clinical trials data transparency

by ANCEL.LA SANTOS QUINTANO

Today, the British Medical Journal published the Cochrane Collaboration’s updated systematic review on Tamiflu (oseltamivir).

The inclusion in the review of clinical study reports (CSRs)—comprehensive documents prepared by the pharmaceutical industry for regulatory processes—has been crucial to uncovering the true effects of the drug.

Selling Sickness through unbranded disease awareness campaigns?

European legislation prohibits advertising of products that have prescription-only status, as well as stating that advertising of medicinal products, when it is allowed, should neither be misleading nor inconsistent with the summary of product characteristics.

Key relevant underlying principles within the European legislation and the WHO Ethical Criteria for Medicinal Drug Promotion include avoidance of activities that take undue advantage of people’s concerns for their own health,

12

START TYPING AND PRESS ENTER TO SEARCH